Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00593541
Other study ID # 200210689
Secondary ID
Status Terminated
Phase N/A
First received January 3, 2008
Last updated May 24, 2017
Start date May 1999
Est. completion date July 2014

Study information

Verified date May 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This Protocol is intended to facilitate development and testing of new cardiovascular MRI software capabilities by UC Davis Research Faculty, as well as to facilitate the evaluation of new software capabilities provided by GE and Siemens.


Description:

This protocol will permit normal subjects, as well as patients with suspected or proven medical conditions, to undergo MRI studies using the new software capabilities. This Protocol is not restricted to imaging of a particular organ system or disease. The Protocol does not involve injection of any contrast agent, or other minimally-invasive or invasive procedure. It is intended only for those cases for which the only requirement of the subject is to relax and lie still while imaging is being performed.


Recruitment information / eligibility

Status Terminated
Enrollment 42
Est. completion date July 2014
Est. primary completion date July 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older

- Ability to give informed, written consent

- Not Pregnant or breastfeeding

Exclusion Criteria:

- Electrically, magnetically, or mechanically activated implants (for example, cardiac-pacemakers)

- Ferromagnetic implant, such as an aneurysm clip, surgical clip, or prosthesis

- History of uncontrolled claustrophobia

Study Design


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Outcome

Type Measure Description Time frame Safety issue
Primary Extend or generalize certain capabilities, such as new data acquisition pulse sequences, new image processing and analysis software for structural and functional analysis of the MR images Post-scanning
Secondary Improve image quality by various techniques (e.g. reducing the effects of motion) Post-scanning
See also
  Status Clinical Trial Phase
Completed NCT02910635 - A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers Phase 1